Personal Finance

Why Cynosure, Inc. Is Rising Today

Gettyimages
Gettyimages

Image source: Getty Images.

What happened

Shares of Cynosure (NASDAQ: CYNO) , a laser maker whose products are used in aesthetic and medical procedures, rose by double-digits in early morning trading on Monday in response to a report that suggests the company is looking to sell itself.

So what

Traders are responding to a Bloomberg article that states Cynosure is "exploring strategic options including a sale." Bloomberg states that the company is discussing the matter with financials advisors. All of this information is coming from "people familiar with the matter."

While the article was light on details, it did suggests that big companies in the aesthetic market -- such as Botox maker Allergan Plc -- could be interested in making an offer. That news caused an analyst from Northland Capital to speculate that Cynosure's stock could fetch as much as $60 per share or more in a deal. That figure represents a strong premium to Friday's closing price of $43.85.

As of the time of this writing, neither Cynosure or Allergan have been willing to comment on the merits of this information.

Now what

Cynosure's recent financial performance has been extremely strong, so perhaps it isn't much of a surprise to see that the company could be an acquisition target. Last quarter, Cynosure produced revenue growth of 36%, expanded its margins, and grew its net income by 43%. Those are solid results that more than justify the company's premium valuation.

Of course, without official confirmation from Cynosure, it is hard to know what to make of Bloomberg's report. Potential shareholders should do their best to ignore today's price action and should only consider buying shares if they believe Cynosure is a compelling investing idea based on its own merits.

10 stocks we like better than Cynosure

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now...and Cynosure wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of January 4, 2017.

Brian Feroldi has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Stocks

The Motley Fool

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Learn More